REDMILE — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Sensorionsensorion.com inFeb 2024

Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.

Co-investorsSofinnova Partners Invus Sanofi Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.